Managing patients with type1 diabetes when fasting Ramadan is very challenging. Insulin pump offers the advantage of flexibility and precision to administering insulin and has been proven to reduce severe hypoglycemia compared to multi-dose injection (MDI). However, there are extremely limited studies on the difference between insulin pump compared to MDI on the incidence of hypoglycemia and other acute complications during fasting Ramadan The investigators hypothesized that insulin pump would be associated with less hypoglycemic events during fasting Ramadan compared to MDI without deterioration in glycemic control. Results of this study are descriptive but will fill a current gap in knowledge and may contribute to development of future guidelines for the management of type1DM during Ramadan.
Study Type
OBSERVATIONAL
Enrollment
142
National Guards Hospital
Dammam, Saudi Arabia
Incidence of hypoglycemia
Rates of hypoglycemia during fasting ramadan in insulin pump users and MDI users \[Hypoglycemia defined as blood glucose level ≤ 70 mg/dl ( 3.9 mmol/l)\]
Time frame: 5 weeks
Number of fasting days lost
To estimate the number of days they needed to brake their fast due to acute complications (hypoglycemia, severe hyperglycemia, or DKA).
Time frame: 5 weeks
Glycemic control
To assess the glycemic control in the two groups using HbA1c and Fructosamine assays.
Time frame: Two (2) months
overnight hypoglycemia
To estimate the rates of overnight hyperglycemia in both groups.
Time frame: 5 weeks
Rate of acute complications
To estimate presence of severe hyperglycemia and /or DKA episodes in both groups
Time frame: 5 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.